01:59 PM EDT, 03/26/2025 (MT Newswires) -- OSR (OSRH) shares surged 116% amid heavy trading after the company's Vaximm subsidiary said Wednesday the final data from a phase 2a trial showed its investigational vaccine VXM01 in combination with avelumab "could offer meaningful clinical benefit" in patients with recurrent glioblastoma, a type of aggressive brain cancer.

Intraday trading volume catapulted to over 75.2 million shares from a daily average of about 1.2 million.

VivoPower International ( VVPR ) said Wednesday it is in advanced talks with Abu Dhabi-based Energi Holdings on an unsolicited all-cash takeover bid for $120 million. Negotiations between VivoPower's ( VVPR ) board and Energi are expected to be completed by April 2.

Shares soared 75% as intraday trading volume surged to more than 132 million from a daily average of about 2.7 million.

SurgePays ( SURG ) said overnight that it expects revenue to exceed $200 million over the next 12 months, compared with sales of $60.9 million reported in 2024.

Shares jumped 61% as intraday trading volume soared to over 63.9 million from a daily average of roughly 295,000.

Price: 3.46, Change: +1.86, Percent Change: +116.44